PharmaCyte Biotech (PMCB) Institutional Ownership $1.81 -0.06 (-3.21%) (As of 10/31/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for PharmaCyte Biotech (NASDAQ:PMCB)CurrentInstitutional OwnershipPercentage34.24%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$576.78KNumber ofInstitutional Sellers(last 12 months)0 Get PMCB Insider Trade Alerts Want to know when executives and insiders are buying or selling PharmaCyte Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PMCB Institutional Buying and Selling by Quarter Ad Behind the MarketsUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> PharmaCyte Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2024K2 Principal Fund L.P.327,503$776K0.1%+7.5%3.876% 2/14/2024K2 Principal Fund L.P.304,613$655K0.1%+17.8%3.534% 11/15/2023Sabby Management LLC97,124$204K0.1%N/A1.106% 11/13/2023K2 Principal Fund L.P.258,481$543K0.1%+67.6%2.944% 10/17/2023Equitec Proprietary Markets LLC82,727$174K0.0%+34.7%0.942% 8/15/2023K2 Principal Fund L.P.154,232$441K0.1%-78.7%1.757% 8/14/2023CSS LLC IL13,186$38K0.0%N/A0.150% 7/12/2023Equitec Proprietary Markets LLC61,415$176K0.1%-81.4%0.366% 5/11/2023K2 Principal Fund L.P.723,271$2.06M0.3%-1.2%4.146% 2/10/2023K2 Principal Fund L.P.732,105$2.15M0.3%+19.8%3.909% 1/10/2023FNY Investment Advisers LLC31,100$90K0.1%N/A0.166% 10/26/2022 IQ EQ FUND MANAGEMENT IRELAND Ltd38,771$93K0.0%N/A0.187% 10/11/2022Equitec Proprietary Markets LLC330,694$794K0.2%-3.6%1.594% 10/4/2022Csenge Advisory Group200,104$480K0.0%N/A0.964% 7/18/2022Equitec Proprietary Markets LLC342,994$768K0.2%+10.9%1.655% 5/17/2022Shay Capital LLC944,666$2.17M0.3%+42.6%4.559% 4/25/2022FNY Investment Advisers LLC59,066$135K0.1%N/A0.285% 4/22/2022Equitec Proprietary Markets LLC309,294$711K0.2%+19.6%1.493% 2/15/2022Shay Capital LLC662,337$1.66M0.3%+4,434.7%3.197% 1/31/2022Equitec Proprietary Markets LLC258,694$647K0.1%N/A1.249% 11/16/2021Schonfeld Strategic Advisors LLC88,200$280K0.0%N/A0.426% 11/12/2021 NorthRock Partners LLC37,164$118K0.0%N/A0.179% (Data available from 1/1/2016 forward) PMCB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PMCB shares? During the previous two years, the following institutional investors and hedge funds held shares of PharmaCyte Biotech shares: K2 Principal Fund L.P. ($776K), Sabby Management LLC ($204K), Equitec Proprietary Markets LLC ($174K), and FNY Investment Advisers LLC ($90K), CSS LLC IL ($38K).Learn more on PMCB's institutional investors. What percentage of PharmaCyte Biotech stock is owned by institutional investors? 34.24% of PharmaCyte Biotech stock is owned by institutional investors. Learn more on PMCB's institutional investor holdings. Which institutional investors have been buying PharmaCyte Biotech stock? The following institutional investors have purchased PharmaCyte Biotech stock in the last 24 months: K2 Principal Fund L.P. ($294.21K), Sabby Management LLC ($97.12K), FNY Investment Advisers LLC ($31.10K), Equitec Proprietary Markets LLC ($21.31K), and CSS LLC IL ($13.19K). How much institutional buying is happening at PharmaCyte Biotech? Institutional investors have bought a total of 456,935 shares in the last 24 months. This purchase volume represents approximately $1.10M in transactions. Which PharmaCyte Biotech major shareholders have been selling company stock? The following institutional investors have sold PharmaCyte Biotech stock in the last 24 months: K2 Principal Fund L.P. ($577.87K), and Equitec Proprietary Markets LLC ($269.28K). How much institutional selling is happening at PharmaCyte Biotech? Institutional investors have sold a total of 847,152 shares in the last 24 months. This volume of shares sold represents approximately $2.42M in transactions. Related Companies AVTE Institutional Ownership RAPT Institutional Ownership MURA Institutional Ownership STTK Institutional Ownership RPHM Institutional Ownership DTIL Institutional Ownership THTX Institutional Ownership OMGA Institutional Ownership VNRX Institutional Ownership CLDI Institutional Ownership This page (NASDAQ:PMCB) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmaCyte Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PharmaCyte Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.